Related Experiment Videos
[Postpolio syndrome. Neurologic and psychiatric aspects]
M-A Weber1, P Schönknecht, J Pilz
1Abteilung Neurologie und Poliklinik, Neurologische Universitätsklinik Heidelberg. m.a.weber@dkfz.de
Der Nervenarzt
|April 17, 2004
Summary
Postpolio syndrome causes new muscle weakness years after polio. This study found over half of patients experienced depression, highlighting its importance in treatment.
Area of Science:
- Neurology
- Psychiatry
Background:
- Postpolio syndrome (PPS) is characterized by new muscle weakness in individuals with a history of acute paralytic poliomyelitis.
- Understanding the full spectrum of PPS, including neurological and psychiatric manifestations, is crucial for effective patient management.
Purpose of the Study:
- To describe the clinical signs, focusing on neurological and psychiatric aspects, of postpolio syndrome.
- To evaluate the treatment and outcomes in a cohort of patients diagnosed with PPS.
Main Methods:
- Clinical evaluation of 16 patients diagnosed with postpolio syndrome.
- Assessment of depressive symptoms using the Hamilton Depression Scale and Geriatric Depression Scale.
- Review of patient history regarding acute poliomyelitis and subsequent development of PPS.
Main Results:
- Postpolio syndrome presented at a median age of 57.5 years, a median of 41 years after the initial polio infection.
- All patients experienced weakness in previously affected muscles; 37.5% developed new weakness in unaffected muscles.
- Depressive episodes, meeting ICD-10 criteria, were identified in 53% of patients.
Conclusions:
- New muscle weakness in postpolio syndrome can affect both previously and newly involved muscles.
- A significant proportion of postpolio syndrome patients exhibit depressive episodes.
- Recognizing and integrating the treatment of depression into physiotherapy-based management is essential for patients with postpolio syndrome.